From June 17 to 22, Daewoong Pharm and DNC Aesthetics participated in the international aesthetic medicine conference, ‘AMUSE 2025 (Aesthetic Medicine Updates Seminar and Exhibition),’ held at Jakarta Science Academy. The event showcased the companies’ flagship aesthetic products and comprehensive treatment education programs to a wide audience of medical professionals.
Hosted by the Jakarta Science Academy, the conference attracted over 1,200 healthcare providers, including dermatologists and plastic surgeons, who gathered to exchange the latest trends and techniques in aesthetic medicine.
Under the theme ‘Leading a New Generation in the Aesthetic Industry (Move to NEW GEN),’ Daewoong Pharm and DNC collaborated to operate a joint exhibition booth, introducing a suite of integrated aesthetic solutions centered around the highly purified botulinum toxin ‘Nabota’. Their display featured core products such as the calcium hydroxyapatite-based skin booster ‘FasTem’, premium hyaluronic acid (HA) filler ‘Declace’, and PDO thread for lifting ‘Lux’.
This initiative was orchestrated by ‘KIIMOT’ (Korea-Indonesia Integrated Marketing Operation Taskforce), a joint marketing organization launched by Daewoong Pharm and DNC. Built around the ‘DEEP’ (Daewoong·DNC Medical-Aesthetic Expert Program) training system, KIIMOT aims to strengthen education on complex aesthetic procedures between Korea and Indonesia.
During the conference, local Indonesian aesthetic physicians performed live demonstrations and delivered lectures. Dr. Bae, director of It’s Me Clinic, showcased procedures for lower face lifting and masseter reduction, while Dr. Jung presented on combined treatments using Nabota and FasTem, sharing practical insights with attending professionals.
Dr. Bae commented, “Nabota’s quick onset and long-lasting effects make it ideal for Indonesia’s medical practices, and I’m pleased to share these skills with local doctors.” Dr. Jung added, “The combined procedures are key to personalized patient care, and sharing these techniques internationally is meaningful.”
Hachang Woo, head of the KIIMOT aesthetic division, stated, “We will develop local CPR strategies based on Daewoong and DNC’s world-class products, aligned with Indonesian market needs. Through the DEEP program, we will also focus on cultivating local medical professionals.”
Daewoong Pharm plans to officially launch Nabota in Indonesia in July, aiming to expand awareness of its full portfolio of aesthetic products via targeted marketing led by KIIMOT, along with promoting the brand’s innovative offerings.
